| Application no. and date | 09153375.2 (espacenet) (Federated) (European Patent Register), 20010207 | | Patent/reg. no. and date | DK/EP 2067772, 20110413 | | Publication date | 20090610 | | Priority no. and date | GB 0002740, 20000207 | | EP pub. no. and date |
EP 2067772 20090610 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 141655 | | Inventor | Fünfschilling, Peter, Ochsengasse 62
4123 Allschwil, CH,
Beutler, Ulrich, Im Lohgraben 42
4104 Oberwil, CH,
Zaugg, Werner, Waltersgrabenweg 15
4125 Reihen, CH,
Kaufmann, Daniel, Novartis Pharma AG
Postfach
4002 Basel, CH,
Lohse, Olivier, 7 rue de Phaffans
90150 Eguenigue, FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07C 237/30 (2006.01) , C07C 271/28 (2006.01) , C07D 223/22 (2006.01) | | Title | Dibenz[b,f]azepin-mellemprodukter | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
